138 related articles for article (PubMed ID: 17937927)
21. Self-assembled monolayer of a pepstatin fragment as a sensing element for aspartyl proteases.
Kitano H; Makino Y; Kawasaki H; Sumi Y
Anal Chem; 2005 Mar; 77(6):1588-95. PubMed ID: 15762561
[TBL] [Abstract][Full Text] [Related]
22. Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cells.
Reich M; Wieczerzak E; Jankowska E; Palesch D; Boehm BO; Burster T
Immunol Lett; 2009 Apr; 123(2):155-9. PubMed ID: 19428564
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Seelmeier S; Schmidt H; Turk V; von der Helm K
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6612-6. PubMed ID: 3045820
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of 1,4-beta-D-xylan xylanohydrolase by the specific aspartic protease inhibitor pepstatin: probing the two-step inhibition mechanism.
Vathipadiekal V; Rao M
J Biol Chem; 2004 Nov; 279(45):47024-33. PubMed ID: 15317808
[TBL] [Abstract][Full Text] [Related]
25. Structure-Activity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor with Antiproliferative Properties: The Unique Role of the AMPA-Based Vector.
Vezenkov LL; Sanchez CA; Bellet V; Martin V; Maynadier M; Bettache N; Lisowski V; Martinez J; Garcia M; Amblard M; Hernandez JF
ChemMedChem; 2016 Feb; 11(3):302-8. PubMed ID: 26639308
[TBL] [Abstract][Full Text] [Related]
26. Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic.
Kim YM; Lee MH; Piao TG; Lee JW; Kim JH; Lee S; Choi KM; Jiang JH; Kim TU; Park H
J Biochem; 2006 Feb; 139(2):189-95. PubMed ID: 16452306
[TBL] [Abstract][Full Text] [Related]
27. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin.
Diment S
J Immunol; 1990 Jul; 145(2):417-22. PubMed ID: 1694878
[TBL] [Abstract][Full Text] [Related]
28. Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopes.
Zou J; Henderson L; Thomas V; Swan P; Turner AN; Phelps RG
J Am Soc Nephrol; 2007 Mar; 18(3):771-9. PubMed ID: 17287425
[TBL] [Abstract][Full Text] [Related]
29. Statistical coupling analysis of aspartic proteinases based on crystal structures of the Trichoderma reesei enzyme and its complex with pepstatin A.
Nascimento AS; Krauchenco S; Golubev AM; Gustchina A; Wlodawer A; Polikarpov I
J Mol Biol; 2008 Oct; 382(3):763-78. PubMed ID: 18675276
[TBL] [Abstract][Full Text] [Related]
30. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E.
Bennett K; Levine T; Ellis JS; Peanasky RJ; Samloff IM; Kay J; Chain BM
Eur J Immunol; 1992 Jun; 22(6):1519-24. PubMed ID: 1601038
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans.
Cadicamo CD; Mortier J; Wolber G; Hell M; Heinrich IE; Michel D; Semlin L; Berger U; Korting HC; Höltje HD; Koksch B; Borelli C
Biochem Pharmacol; 2013 Apr; 85(7):881-7. PubMed ID: 23262278
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
Manceur A; Wu A; Audet J
Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
[TBL] [Abstract][Full Text] [Related]
33. Pepstatin-insensitive carboxyl proteinases.
Oda K; Takahashi S; Shin T; Murao S
Adv Exp Med Biol; 1995; 362():529-42. PubMed ID: 8540367
[No Abstract] [Full Text] [Related]
34. Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin.
Yamada T; Liepnieks J; Benson MD; Kluve-Beckerman B
J Immunol; 1996 Jul; 157(2):901-7. PubMed ID: 8752944
[TBL] [Abstract][Full Text] [Related]
35. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
36. Epitope-directed processing of specific antigen by B lymphocytes.
Davidson HW; Watts C
J Cell Biol; 1989 Jul; 109(1):85-92. PubMed ID: 2473083
[TBL] [Abstract][Full Text] [Related]
37. Parasite killing in Plasmodium vivax malaria by nitric oxide: implication of aspartic protease inhibition.
Sharma A; Eapen A; Subbarao SK
J Biochem; 2004 Sep; 136(3):329-34. PubMed ID: 15598889
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A.
von der Helm K; Gürtler L; Eberle J; Deinhardt F
FEBS Lett; 1989 Apr; 247(2):349-52. PubMed ID: 2469601
[TBL] [Abstract][Full Text] [Related]
39. A multifunctional protease inhibitor to regulate endolysosomal function.
van Kasteren SI; Berlin I; Colbert JD; Keane D; Ovaa H; Watts C
ACS Chem Biol; 2011 Nov; 6(11):1198-204. PubMed ID: 21910425
[TBL] [Abstract][Full Text] [Related]
40. Aspartic protease from Aspergillus niger: Molecular characterization and interaction with pepstatin A.
Purushothaman K; Bhat SK; Singh SA; Marathe GK; Appu Rao ARG
Int J Biol Macromol; 2019 Oct; 139():199-212. PubMed ID: 31374272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
